Ensuring quality control in a COVID-19 clinical trial during the pandemic: The experience of the Inserm C20–15 DisCoVeRy study

SETTING: Health measures taken during the pandemic deeply modified the clinical research practices. At the same time, the demand for the results of the COVID-19 trials was urgent. Thus, the objective of this article is to share Inserm's experience in ensuring quality control in clinical trials...

Descripción completa

Detalles Bibliográficos
Autores principales: Fougerou-Leurent, Claire, Delmas, Christelle, Saillard, Juliette, Dumousseaux, Marina, Ferrane, Assia, Mercier, Noémie, Terzic, Vida, Le Mestre, Soizic, Dechanet, Aline, Belhadi, Drifa, Metois, Annabelle, Burdet, Charles, Mentré, France, Noret, Marion, Diallo, Alpha, Petrov-Sanchez, Ventzislava, Couffin-Cadiergues, Sandrine, Hites, Maya, Ader, Florence, Esperou, Hélène
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10250249/
https://www.ncbi.nlm.nih.gov/pubmed/37302469
http://dx.doi.org/10.1016/j.cct.2023.107267

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10250249/
https://www.ncbi.nlm.nih.gov/pubmed/37302469
http://dx.doi.org/10.1016/j.cct.2023.107267

Ejemplares similares